Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Toronto S.E.
2026-09-16
|
5-day change | 1st Jan Change | ||
| 0.1050 CAD | +5.00% |
|
-25.00% | -19.23% |
| Market Cap | 39.65M 28.45M 24.66M 23.3M 21.16M 2.73B 39.89M 278M 108M 1.38B 107M 105M 4.41B | P/E 2026 * |
-4.2x | P/E 2027 * | -3.5x |
|---|---|---|---|---|---|
| Enterprise Value | 39.65M 28.45M 24.66M 23.3M 21.16M 2.73B 39.89M 278M 108M 1.38B 107M 105M 4.41B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 15.9x |
| Free-Float |
89.49% | Yield 2026 * |
-
| Yield 2027 * | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| SVA | End-of-day quote | |
Toronto S.E.
| SVA | Delayed | |
|
OTC Markets
| SEOVF | Delayed | |
|
Tradegate
| PSH0 | Real-time | |
|
Deutsche Boerse AG
| PSH0 | Delayed | |
|
Börse Stuttgart
| PSH0 | Delayed | |
|
Xetra
| PSH0 | Delayed | |
|
Boerse Muenchen
| PSH0 | Real-time |
| 1 day | +5.00% | ||
| 1 week | -25.00% | ||
| Current month | -4.55% | ||
| 1 month | -4.55% | ||
| 3 months | -25.00% | ||
| 6 months | -34.38% | ||
| Current year | -19.23% |
| 1 week | 0.1 |  | 0.15 |
| 1 month | 0.1 | | 0.15 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.2 |
| 3 years | 0.1 | | 0.83 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 2024-08-11 |
James Parsons
DFI | Director of Finance/CFO | 60 | 2024-10-10 |
David Burke
IRC | Investor Relations Contact | - | 2024-10-10 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 2012-04-18 |
Steven Sangha
BRD | Director/Board Member | - | 2023-04-23 |
David Paterson
BRD | Director/Board Member | - | 2024-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/3/26 | Sell | Company | -115,000 | 0.0305% | ||
| 5/22/26 | Option | Chairman | 228,912 | 0.0658% | ||
| 5/22/26 | Option | Director | 260,000 | 0.0748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.00% | -25.00% | -41.67% | -86.71% | 28.45M | |
| +1.16% | +3.40% | -24.39% | -2.74% | 109B | |
| -0.70% | +1.17% | -24.33% | -1.05% | 11.79B | |
| -4.78% | -9.08% | +98.51% | +117.61% | 9.64B | |
| +0.57% | -2.19% | -53.85% | -71.49% | 3.99B | |
| -1.25% | -3.88% | -29.61% | +21.67% | 2.33B | |
| -2.48% | +9.43% | -9.96% | -65.51% | 2.1B | |
| 0.00% | -2.98% | - | - | 1.82B | |
| +1.19% | -1.78% | -22.36% | -30.15% | 1.52B | |
| Average | -0.14% | -2.54% | -13.46% | -14.79% | 15.83B | |
| Weighted average by Cap. | +0.48% | +2.21% | -16.65% | +2.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 2.5M 1.79M 1.55M 1.47M 1.33M 172M 2.51M 17.54M 6.78M 87.28M 6.74M 6.59M 278M |
| Net income | -11.3M -8.11M -7.03M -6.64M -6.03M -778M -11.37M -79.28M -30.64M -395M -30.46M -29.78M -1.26B | -13.9M -9.97M -8.64M -8.17M -7.42M -957M -13.98M -97.52M -37.68M -485M -37.47M -36.63M -1.55B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-16 | CA$0.1050 | +5.00% | 198,957 |
| 26-09-15 | CA$0.1000 | -9.09% | 983,178 |
| 26-09-14 | CA$0.1100 | -18.52% | 1,227,009 |
| 26-09-11 | CA$0.1350 | -3.57% | 547,514 |
| 26-09-10 | CA$0.1400 | 0.00% | 500,864 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.1050CAD
Average target price
1.000CAD
Spread / Average Target
+852.38%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
